Taikang Asset Management (HK)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Taikang Asset Management (HK)'s LLY Position: Q2 2025 in Review
Taikang Asset Management (HK) sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 500 shares — an estimated $413K sold.
Taikang Asset Management (HK) first reported a position in LLY in Q2 2024 and held it in 4 quarters. The position peaked at $453K in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.
- Taikang Asset Management (HK) reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
- Taikang Asset Management (HK) sold 500 Eli Lilly shares in Q2 2025, an estimated $413K.
- Taikang Asset Management (HK) first reported a position in Eli Lilly in Q2 2024 and held it in 4 quarters.
- Taikang Asset Management (HK)'s Eli Lilly position peaked at $453K in Q2 2024.
- 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.
Based on Taikang Asset Management (HK)'s 13F filing for Q2 2025, filed 13 Aug 2025.